However, the role of endogenous UCPs in cancer is more complex and some aspects must be taken into account when analyzing this apparent contradiction; elevated expression or activity of UCPs—especially UCP2—in cancer cells may be selected during tumor development as an adaptive mechanism. This evidence concerns the gene UCP2 and neoplasm.